International Journal of Pharmaceutical Sciences and Research,
Год журнала:
2023,
Номер
14(9)
Опубликована: Сен. 1, 2023
Parkinson's
disease
(PD)
is
the
second
most
prevalent
type
of
neurodegenerative
disorder
and
a
chronic,
progressive
condition.In
current
investigation,
we
used
rotenone
(ROT)-developing
rat
model
PD
to
assess
neuroprotective
efficacy
ethanolic
Withania
somnifera
root
extract
(EWSR)
in
comparison
known
neuroprotectants
i.e.,
Doxycycline
(Doxy),
ellagic
acid
(EA)
individually
combination
(EWSR-Doxy-EA).Male
Wistar
rats
were
given
ROT
at
dose
2.5
mg/kg
body
weight
daily
for
4
weeks
develop
invivo
model.Once
confirmed,
treated
with
individual
next
5
kept
under
observation
7
days
reversal
PD.ROT
administration
has
altered
behavioural
parameters
(Cognitive,
motor
dysfunction,
sniffing,
grooming,
raring,
crossing,
etc.)
neurotransmitter
profile
(Acetylcholine,
epinephrine,
nor-epinephrine,
dopamine,
glutamate
aspartate)
rats.The
ameliorated
deleterious
effects
restored
cognitive
control
by
rectifying
levels
neurotransmitters
which
are
responsible
functions.EWSR
protective
was
significantly
better
that
(Doxy
EA)
EWSR
increased
when
combined
other
neuroprotectants.Based
on
study
observations,
it
can
be
inferred
good
agent
act
as
potential
alternative
therapeutic
approach
or
drugs
treating
diseases.INTRODUCTION:
progressive,
late-onset
condition
marked
development
fibrillar
cytoplasmic
inclusions
containing
α-synuclein
ubiquitin
relatively
selective
nigrostriatal
dopaminergic
loss.
British Journal of Pharmacology,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 3, 2024
Background
and
purpose
Atherosclerosis
is
the
basis
of
cardiovascular
disease.
Ferroptosis
a
form
programmed
cell
death
characterized
by
lipid
peroxidation,
which
contributes
to
atherogenesis.
The
plant
extract
PNS
(
Panax
notoginseng
saponins
),
containing
main
active
ingredients
,
exhibits
anti‐atherogenic
properties.
Herein,
we
determined
whether
its
major
components
could
attenuate
atherosclerosis
suppressing
ferroptosis
revealed
underlying
mechanism(s).
Experimental
approach
effects
their
association
with
inhibition
was
in
apoE
−/−
mice.
In
vitro,
anti‐ferroptotic
effect
mechanism(s)
were
demonstrated
presence
inducers.
Expression
markers
ubiquitination
Keap1
evaluated
USP2
macrophages.
Finally,
knockout
using
mice
treated
high‐fat
diet
(HFD)
AAV‐PCSK9.
Key
results
inhibited
vivo.
suppressed
ferroptosis‐aggravated
foam
formation
inflammation
vitro.
Mechanistically,
activated
Nrf2
antagonizing
Keap1,
attributed
expression.
antagonized
inflammation,
thus
mitigating
atherosclerosis.
abolished
inhibitory
on
Conclusion
implications
reduced
USP2‐mediated
de‐ubiquitination
promoted
degradation,
thereby
activating
Nrf2,
improving
iron
metabolism
reducing
contributing
an
anti‐atherosclerotic
outcome.
Our
study
PNS.
Journal of Dental Research,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 14, 2024
Parkinson’s
disease
(PD)
is
a
neurodegenerative
condition
characterized
by
the
progressive
and
selective
loss
of
dopaminergic
(DAergic)
neurons
in
midbrain.
The
replacement
neuromelanin
(NM)–containing
DAergic
substantia
nigra
enhancement
NM
concentration
could
offer
promising
safe
approach
to
treating
PD
symptoms.
objective
this
study
was
investigate
compare
potential
human
periapical-cysts
mesenchymal
stem
cells
(hPCy-MSCs)
dental
pulp
(DPSCs)
differentiate
into
NM-producing
generate
functional
3-dimensional
(3D)
midbrain-like
organoids
vitro.
We
assessed
changes
morphology
behavior
neuron-like
(NLCs)
as
well
expression
molecular
markers
characterizing
neurons.
Furthermore,
we
observed
electrically
active
functionally
mature
means
electrophysiological
assays,
dosage
quantification
dopamine
release
high-performance
liquid
chromatography.
Our
results
demonstrate
for
first
time
that
both
hPCy-MSCs
DPSCs
are
capable
differentiating
NLCs,
further
confirmed
increase
lactate
levels
medium
exposed
neurogenic
conditions.
Importantly,
have
induced
such
NLCs
Finally,
3D
been
produced
from
oral
cells:
they
appear
neurosphere-like
structures
diffusely
expressing
neural
marker
β-III
tubulin
containing
NM-like
granules.
findings
open
up
novel
fascinating
opportunity
rethink
cells,
derived
models,
strategic
reliable
tool
unveiling
alterations.
Cisplatin
(CDDP),
an
important
chemotherapeutic
agent,
could
result
in
potential
hepatotoxicity,
but
the
precious
molecular
mechanisms
remain
unclear.
In
this
study,
protective
effect
of
ellagic
acid
(EA)
on
CDDP
exposure-induced
hepatotoxicity
and
underlying
were
investigated
using
a
mouse
model.
Mice
randomly
divided
into
control,
model,
EA100
(i.e.,
EA
100
mg/kg/day),
plus
25,
50,
mg/kg/day.
all
CDDP-treated
groups
intraperitoneally
injected
with
20
mg/kg/day
for
2
days.
co-treatments,
mice
orally
administrated
7
Our
results
found
that,
compared
to
control
group,
treatment
resulted
liver
dysfunction,
oxidative
stress,
hepatocyte
necrosis,
which
are
effectively
revised
by
supplementation
dose-dependent
manner.
Meanwhile,
inhibited
CDDP-induced
elevation
caspases-9
-3
activities
tissues
mice.
Furthermore,
significantly
downregulated
increases
NF-κB,
IL-1β,
TNF-α,
IL-6
proteins
mRNAs,
while
further
upregulated
expression
Nrf2,
HO-1
mRNAs.
Taken
together,
our
reveal
that
ameliorate
CCDP-induced
injury
via
opposite
regulation
Nrf2/HO-1
NF-kB
pathways.
International Journal of Pharmaceutical Sciences and Research,
Год журнала:
2023,
Номер
14(9)
Опубликована: Сен. 1, 2023
Parkinson's
disease
(PD)
is
the
second
most
prevalent
type
of
neurodegenerative
disorder
and
a
chronic,
progressive
condition.In
current
investigation,
we
used
rotenone
(ROT)-developing
rat
model
PD
to
assess
neuroprotective
efficacy
ethanolic
Withania
somnifera
root
extract
(EWSR)
in
comparison
known
neuroprotectants
i.e.,
Doxycycline
(Doxy),
ellagic
acid
(EA)
individually
combination
(EWSR-Doxy-EA).Male
Wistar
rats
were
given
ROT
at
dose
2.5
mg/kg
body
weight
daily
for
4
weeks
develop
invivo
model.Once
confirmed,
treated
with
individual
next
5
kept
under
observation
7
days
reversal
PD.ROT
administration
has
altered
behavioural
parameters
(Cognitive,
motor
dysfunction,
sniffing,
grooming,
raring,
crossing,
etc.)
neurotransmitter
profile
(Acetylcholine,
epinephrine,
nor-epinephrine,
dopamine,
glutamate
aspartate)
rats.The
ameliorated
deleterious
effects
restored
cognitive
control
by
rectifying
levels
neurotransmitters
which
are
responsible
functions.EWSR
protective
was
significantly
better
that
(Doxy
EA)
EWSR
increased
when
combined
other
neuroprotectants.Based
on
study
observations,
it
can
be
inferred
good
agent
act
as
potential
alternative
therapeutic
approach
or
drugs
treating
diseases.INTRODUCTION:
progressive,
late-onset
condition
marked
development
fibrillar
cytoplasmic
inclusions
containing
α-synuclein
ubiquitin
relatively
selective
nigrostriatal
dopaminergic
loss.